Author

Hannah Botting

Observed names: Botting, Hannah, H. Botting

Institutions: Queen's University, Kingston General Hospital, Kingston Health Sciences Centre

Observed institutions: Queen's University, Kingston General Hospital, Kingston Health Sciences Centre

OpenAlex ID: A5009002978

Characterizing the symptomatology and pathophysiology of allergic rhinitis using a nasal allergen challenge model – a subset of the allergic rhinitis microbiome study

2025 · Sophia Linton, Lubnaa Hossenbaccus, et al. · Allergy Asthma and Clinical Immunology · 6

Analyzing phenotypes post-exposure in allergic rhinitis in the environmental exposure unit

2024 · Abigail Davis, Sophia Linton, et al. · Annals of Allergy Asthma & Immunology · 3

Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective

2022 · Kayley Xu, Sophia Linton, et al. · Annals of Allergy Asthma & Immunology · 3

Clinical validation of controlled exposure to cat dander in the Specialized Particulate Control Environmental Exposure Unit (SPaC-EEU)

2025 · Lubnaa Hossenbaccus, Sophia Linton, et al. · Allergy Asthma and Clinical Immunology · 2

Biphasic anaphylaxis in a Canadian tertiary care centre: an evaluation of incidence and risk factors from electronic health records and telephone interviews

2025 · Anne K. Ellis, Lubnaa Hossenbaccus, et al. · Allergy Asthma and Clinical Immunology · 2

Anxiety in adults with asthma during the coronavirus disease 2019 pandemic: a Canadian perspective

2023 · Sophia Linton, Kayley Xu, et al. · Allergy Asthma and Clinical Immunology · 2

Characterizing the nasal microbiome using a nasal allergen challenge model

2026 · Sophia Linton, Calvin Sjaarda, et al. · Journal of Allergy and Clinical Immunology · 1

Staphylococcus aureus nasal carriage is associated with faster symptom resolution following nasal allergen challenge in ragweed-allergic participants: a subset of the Allergic Rhinitis Microbiome Study

2025 · Sophia Linton, Lubnaa Hossenbaccus, et al. · Allergy Asthma and Clinical Immunology · 1

Development and translational validation of a novel mouse model for allergic rhinitis

2026 · Lubnaa Hossenbaccus, Wil P. Taylor, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Clinical symptoms and biomarkers of cat allergen–induced allergic rhinitis using the nasal allergen challenge model

2026 · Lubnaa Hossenbaccus, Sophia Linton, et al. · Annals of Allergy Asthma & Immunology

Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS): Improvement in asthma symptoms and quality of life 6-months post-treatment

2026 · Abigail Davis, Sarah Garvey, et al. · Journal of Allergy and Clinical Immunology

Tezepelumab in Allergic Rhinitis and Asthma Study (tezars): Improvement in Nasal Symptoms 6-months Post-treatment

2025 · A. Davis, S. Garvey, et al. · Annals of Allergy Asthma & Immunology

Nasal Cytokine Insights from Allergic and Non-Allergic Participants Following Cat Allergen Exposure in the Specialized Particulate Control Environmental Exposure Unit (SPaC-EEU)

2025 · Lubnaa Hossenbaccus, Sophia Linton, et al. · Journal of Allergy and Clinical Immunology

Clinical Validation of the Specialized Particulate Control Environmental Exposure Unit (spac-eeu) for Cat Dander Exposure

2024 · L. Hossenbaccus, S. Garvey, et al. · Annals of Allergy Asthma & Immunology

Biphasic Anaphylaxis: A prospective evaluation of incidence, risk factors, preventative features, and severity in a Canadian tertiary care centre

2020 · Leila Alenazy, Grace Yin, et al. · Journal of Allergy and Clinical Immunology

Works count: 19

Citation count: 20

H-index: 3

I10-index: